ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1934

What Is the Significance of Periarterial Temporal Small Vessel Inflammation (SVI) on Temporal Artery Biopsy (TAB) in the Diagnosis of Vasculitis? A Systematic Review and Meta-analysis

Elise Belilos1, Steven Carsons2 and Sonya Mehta1, 1NYU Winthrop Hospital, Mineola, NY, 2NYU Long Island School of Medicine, Mineola, NY

Meeting: ACR Convergence 2020

Keywords: giant cell arteritis, Polymyalgia Rheumatica (PMR), Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Isolated inflammation of small vessels including capillaries, venules and arterioles surrounding a normal temporal artery (SVI) in patients suspected of having giant cell arteritis (GCA) has been described in the literature. However, the significance of this finding remains controversial. Authors have described SVI as highly suggestive of vasculitis while others consider it to be a non-specific finding associated with aging, infection and malignant disease. We performed a systematic review of the literature in order to characterize the diagnoses, clinical, and laboratory manifestations of patients with periarterial temporal small vessel inflammation as a sole finding on TAB

Methods: A search of the English language literature from 1990-2019 was performed using the following search terms: temporal artery, giant cell arteritis, vasculitis, small vessel, inflammation, vasa vasorum, and periarteritis. Data was extracted for cases that displayed isolated inflammation of small blood vessels external to a spared temporal artery on TAB. Clinical diagnosis, clinical and laboratory manifestations and treatment were recorded and included age, sex, presence of headache, polymyalgia rheumatica (PMR), temporal artery (TA) abnormality, fever, visual symptoms, and corticosteroid therapy. Data was extracted from individual studies and pooled odds ratios were calculated.

Results: Eleven studies were identified that provided data on 324 TAB demonstrating inflammation of small blood vessels external to the temporal artery.  One hundred and fifteen (35.5%) were classified as definite or probable GCA and 80 of these (69.6%) had PMR symptoms. Fifty (15.4%) had isolated PMR. Twenty (6.2%), especially those having neutrophilic infiltrates had other forms of vasculitis. The remainder (42.9%) had other illnesses including infection, malignancy or undiagnosed conditions. Five studies reported clinical data on patients with SVI classified as GCA. The mean age was 73.2 years, 65.8% were male, 43.8% had headache, 9.8% had jaw claudication 23.7% had abnormal TA, 22.3% had fever and 30.5% had visual symptoms. Corticosteroid (CS) was administered to 79.4% (range- 39-100); 79% (range 59.6-100) responded.  When SVI was compared to classical GCA, three studies reported significantly fewer SVI patients with jaw claudication whereas 2 studies reported a significant increase in PMR in SVI. Meta-analysis of 4 studies reporting jaw claudication and PMR revealed a significant increase of PMR in SVI (pooled OR 5.92; CI 3.32-10.55; P< 0.001) and less jaw claudication in SVI (pooled OR 0.248; CI 0.13-0.50; P< 0.0001).

Conclusion: Inflammation of capillaries, venules and arterioles surrounding a normal temporal artery on TAB in patients suspected of having giant cell arteritis (GCA) should not be ignored. While the clinical phenotype differs from classical GCA, the high prevalence of PMR, and response to CS suggests that this finding is associated with the PMR-GCA spectrum in a significant proportion of patients.


Disclosure: E. Belilos, None; S. Carsons, None; S. Mehta, None.

To cite this abstract in AMA style:

Belilos E, Carsons S, Mehta S. What Is the Significance of Periarterial Temporal Small Vessel Inflammation (SVI) on Temporal Artery Biopsy (TAB) in the Diagnosis of Vasculitis? A Systematic Review and Meta-analysis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/what-is-the-significance-of-periarterial-temporal-small-vessel-inflammation-svi-on-temporal-artery-biopsy-tab-in-the-diagnosis-of-vasculitis-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-is-the-significance-of-periarterial-temporal-small-vessel-inflammation-svi-on-temporal-artery-biopsy-tab-in-the-diagnosis-of-vasculitis-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology